Epilepsy surgery achieves complete seizure freedom in 60 to 80 percent of appropriately selected drug-resistant patients. Outcome depends on seizure focus location, underlying pathology, and completeness of resection. Surgery is reserved for drug-resistant cases where a resectable seizure focus is confirmed through structured pre-surgical evaluation.
According to Dr. Gurneet Singh Sawhney, Neurosurgeon in Mumbai, “epilepsy surgery offers the highest probability of seizure freedom for appropriately selected drug-resistant patients, outcomes that decades of medication adjustment cannot replicate.”
Presenting with drug-resistant epilepsy and seeking surgical evaluation?
When Does Epilepsy Surgery Achieve Seizure Freedom?
Seizure freedom rates differ by procedure and pathology. These four scenarios carry the highest probability of curative outcome.
- Temporal lobe epilepsy with hippocampal sclerosis: Anterior temporal lobectomy achieves seizure freedom in 70 to 80 percent of cases at one year. And freedom remains above 60 percent at five years, which no medication trial has replicated for this patient group.
- Focal cortical dysplasia with complete resection: Seizure freedom correlates directly with completeness of resection confirmed on post-operative MRI. Complete resection achieves approximately 60 percent seizure freedom incomplete resection reduces this substantially regardless of lesion location.
- Low-grade tumour and cavernous malformation: Resection of epileptogenic cavernous malformations and low-grade tumours including ganglioglioma achieves 70 to 90 percent seizure freedom. This is the highest cure rate across all epilepsy surgery aetiological categories.
- Hemispherotomy for hemispheric epilepsy: Functional hemispherotomy for unilateral hemispheric epilepsy with established hemiplegia achieves seizure freedom in 60 to 70 percent of cases. Rasmussen encephalitis and hemispheric cortical dysplasia are the primary indications.
MRI lesion identification, EEG concordance with imaging, and complete resection are the three factors most consistently linked to seizure-free outcome. Explore epilepsy surgery in Mumbai for drug-resistant epilepsy evaluation at Fortis Hospital Mulund West.
When Does Epilepsy Surgery Not Achieve a Complete Cure?
Not all epilepsy surgery is curative. Palliative procedures reduce seizure frequency without achieving freedom and that distinction must be established before any surgical decision is made.
- Non-lesional epilepsy with poor localisation: Drug-resistant epilepsy without a structural lesion on MRI and without concordant EEG localisation carries significantly lower seizure freedom rates. Outcomes range from 30 to 50 percent. Stereo-EEG is required before candidacy is confirmed or excluded.
- Palliative procedures for generalised epilepsy: Corpus callosotomy, vagus nerve stimulation, and deep brain stimulation reduce seizure frequency rather than eliminate seizures. These neuromodulation procedures apply when bilateral epileptiform activity or absent localised focus makes resection inappropriate.
- Incomplete resection and recurrence: Incomplete resection of the epileptogenic zone is the most common cause of surgical failure. But recurrence is not a final answer — repeat resection, stereotactic radiosurgery, or neuromodulation remain options based on post-operative localisation findings.
- No surgical candidacy: Bilateral independent seizure onset, eloquent cortex involvement, and significant comorbidity make neuromodulation the primary pathway. Serial re-evaluation is warranted because SEEG-guided localisation continues expanding candidacy in previously inoperable cases.
Candidacy is not a one-time decision. Protocols advance, and patients previously deemed non-surgical do become candidates over time.
Families who have read about whether neurological problems can exist with normal scans understand why MRI protocol selection significantly influences lesion detection and candidacy determination.
Why Choose Dr. Gurneet Singh Sawhney?
Dr. Gurneet Singh Sawhney completed a dedicated epilepsy surgery fellowship under Prof. Sugano at Juntendo University, Tokyo, one of Asia’s highest-volume epilepsy surgery programmes, and a functional neurosurgery fellowship under Prof. Taira at Tokyo Women’s Medical University. Two dedicated fellowships. Not general rotations. At Fortis Hospital Mulund West, pre-surgical evaluation incorporates prolonged video EEG, MRI epilepsy protocol, neuropsychological assessment, and functional mapping where the seizure focus is adjacent to eloquent cortex.
Patients receive a candidacy assessment covering whether a resectable focus is identifiable, whether complete resection is achievable without deficit, and what the realistic probability of seizure freedom is for that specific case. The recommendation is based on objective evaluation findings. Call +91 8104310753 to book your consultation.
FAQ's
Can epilepsy be cured by surgery?
Epilepsy surgery achieves seizure freedom in 60 to 80 percent of appropriately selected drug-resistant patients depending on seizure focus location and underlying pathology.
Which epilepsy type has the best surgical outcomes?
Temporal lobe epilepsy with hippocampal sclerosis and tumour-related epilepsy from ganglioglioma or cavernous malformation have the highest seizure freedom rates.
Is epilepsy surgery suitable for all drug-resistant patients?
Surgical candidacy requires a resectable seizure focus confirmed on pre-surgical evaluation and is not appropriate for all drug-resistant epilepsy patients.
What are the options if surgery does not achieve seizure freedom?
Vagus nerve stimulation, corpus callosotomy, and deep brain stimulation are available for patients in whom resective surgery is not feasible.
References
- National Institute of Neurological Disorders and Stroke. Neurological Diagnostic Tests and Procedures. NINDS, NIH.
- Wiebe S, et al. Randomised Trial of Surgery for Temporal Lobe Epilepsy. PubMed Central, NCBI.